日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma

CAF衍生的LRRC15调控巨噬细胞极化并限制PD-1免疫疗法在胶质母细胞瘤中的疗效

Luo, Feifei; Mei, Yan; Li, Yanwen; Yang, Jiahao; Xi, Shaoyan; Cao, Endong; Shen, Cong; Zhou, Dexiang; Wang, Peng; Zhou, Dong; Cai, Haiping

A nomogram for predicting the diagnosis of central malignant tumors based on preoperative clinical characteristics and laboratory indicators: a diagnostic study

基于术前临床特征和实验室指标预测中枢恶性肿瘤诊断的列线图:一项诊断研究

Yang, Jiahao; Cai, Haiping; Zhang, Liang; Alafate, Wahafu; Xi, Shaoyan; Du, Jiahui; Ke, Xueying; Zhang, Yinian; Zhou, Dong

Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer.

开发与昼夜节律相关的预后特征,凸显了 RBM17 作为肝癌干细胞调节因子的作用

Yan Jingsong, Yang Xiao, Lu Jiabin, Wu Shasha, Wang Yanchen, Du Yuyang, Zheng Jingyi, Wang Fenfen, Gao Han, Yang Hui, Xi Shaoyan, Li Yan

A Novel Germline MUTYH Mutation (p.W156∗) in High-Grade Astrocytoma, IDH Mutant

高级别星形细胞瘤中发现一种新的种系MUTYH突变(p.W156∗),IDH突变

Zhang, Lulu; Xi, Shaoyan; Yuan, Lei; Li, Ziteng; Liu, Xiaoyun; Gu, Jiamei; Li, Shuo; Huang, Liyun; Hu, Wanming; Fu, Lingyi

MYCN amplification defines an aggressive phenotype in IDH-mutant gliomas

MYCN扩增定义了IDH突变型胶质瘤的侵袭性表型。

Xie, Xujun; Yan, Qin; Wang, Fang; Lu, Jiabin; Zhang, Yuandong; Xi, Shaoyan

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

VAL-083 对新诊断的 MGMT 未甲基化胶质母细胞瘤患者有效:II 期研究报告

Guo, Chengcheng; Yang, Qunying; Deng, Meiling; Qiu, Xiaoling; Wu, Shaoxiong; Du, Xiaojing; Sai, Ke; Dai, Ziyu; Chen, Zhenghe; Zhang, Ji; Lin, Fuhua; Ke, Chao; Xi, Shaoyan; Hu, Wanming; Zhou, Zhihuan; Li, Jiawei; Cao, Xi; Liao, Yixiang; Lv, Yanchun; Brown, Dennis; Langlands, John; Johnson, Gregory; Bacha, Jeffrey; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Chen, Zhongping

Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge

儿童中枢神经系统肿瘤伴CIC::LEUTX融合基因:诊断挑战

Hou, Yanghao; Du, Yanru; Wang, Juan; Zhang, Xinke; Zhao, Xueyan; Xian, Xinyi; Yuan, Li; Li, Haigang; Wang, Yu; Xi, Shaoyan; Huang, Guan; Zhu, Wenbiao; Wang, Juan; Zhu, Jin; Yu, Qiubo; Cao, Youde; Wu, JingXian; Zeng, Jing; Dong, Gehong; Hu, Wanming

Spinal Cord Astroblastoma With EWSR1-BEND2 Fusion in Female Patients : A Report of Four Cases From China and a Comprehensive Literature Review

女性脊髓星形母细胞瘤伴EWSR1-BEND2融合基因:中国4例病例报告及文献综述

Fu, Lingyi; Lao, I Weng; Huang, Liyun; Ou, Liqiong; Yuan, Lei; Li, Ziteng; Li, Shuo; Hu, Wanming; Xi, Shaoyan

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial

替莫唑胺辅助化疗联合或不联合干扰素α治疗新诊断的高级别胶质瘤患者:一项随机临床试验

Guo, Chengcheng; Yang, Qunying; Xu, Pengfei; Deng, Meiling; Jiang, Taipeng; Cai, Linbo; Li, Jibin; Sai, Ke; Xi, Shaoyan; Ouyang, Hui; Liu, Mingfa; Li, Xianming; Li, Zihuang; Ni, Xiangrong; Cao, Xi; Li, Cong; Wu, Shaoxiong; Du, Xiaojing; Su, Jun; Xue, Xiaoying; Wang, Yiming; Li, Gang; Qin, Zhiyong; Yang, Hui; Zhou, Tao; Liu, Jinquan; Hu, Xuefeng; Wang, Jian; Jiang, Xiaobing; Lin, Fuhua; Zhang, Xiangheng; Ke, Chao; Lv, Xiaofei; Lv, Yanchun; Hu, Wanming; Zeng, Jing; Chen, Zhenghe; Zhong, Sheng; Wang, Hairong; Chen, Yinsheng; Zhang, Ji; Li, Depei; Mou, Yonggao; Chen, Zhongping

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.

USP39 与 SRSF6/HNRNPC 协同作用,通过调节选择性剪接促进肝细胞癌的发生

Zheng Jingyi, Wu Shasha, Tang Mao, Xi Shaoyan, Wang Yanchen, Ren Jun, Luo Hao, Hu Pengchao, Sun Liangzhan, Du Yuyang, Yang Hui, Wang Fenfen, Gao Han, Dai Ziwei, Ou Xijun, Li Yan